Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kevin Charles Gorman Sells 2,274 Shares of Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 2,274 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $134.15, for a total transaction of $305,057.10. Following the completion of the transaction, the chief executive officer now owns […]
More Stories
Iconic Minerals (CVE:ICM) Stock Price Up 33.3% – Here’s What Happened
Iconic Minerals Ltd. (CVE:ICM – Get Free Report)’s stock price rose 33.3% on Wednesday . The stock traded as high...
Ramsay Health Care (OTCMKTS:RMSYF) Shares Up 4.7% – Should You Buy?
Shares of Ramsay Health Care Limited (OTCMKTS:RMSYF – Get Free Report) rose 4.7% on Friday . The stock traded as...
Antofagasta (OTCMKTS:ANFGF) Trading Down 0.5% – Here’s Why
Antofagasta plc (OTCMKTS:ANFGF – Get Free Report)’s share price was down 0.5% during mid-day trading on Friday . The company...
JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:JAGG) Trading 0.1% Higher – Here’s Why
Shares of JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:JAGG – Get Free Report) traded up 0.1% on Friday . The...
Loungers (LON:LGRS) Stock Price Down 0.6% – Here’s Why
Loungers plc (LON:LGRS – Get Free Report)’s share price dropped 0.6% on Friday . The stock traded as low as...
FirstRand (OTCMKTS:FANDF) Trading Down 5% – What’s Next?
Shares of FirstRand Limited (OTCMKTS:FANDF – Get Free Report) dropped 5% on Friday . The stock traded as low as...